Kier resumes pre-construction work at Harlow bioscience campus

Kier resumes pre-construction work at Harlow bioscience campus

Kier resumes planning work on Harlow’s specialist high-containment laboratory project. Its reactivated agreement covers H50 within UKHSA’s wider £3.52bn campus programme.


Kier Group has resumed work under a previously agreed pre-construction services agreement for the H50 high-containment laboratory building at the UK Health Security Agency’s planned Harlow campus. The agreement was reactivated as part of the agency’s wider £3.52bn programme to consolidate its scientific facilities and headquarters in Essex. H50 is intended to accommodate laboratories working with Containment Level 3 and 4 pathogens; the renewed work does not amount to a fresh award for construction of the whole campus.

The 26 October confirmation concerns the reinstatement of Kier’s existing pre-construction role, rather than a new tender award. The UKHSA programme business case identifies reinstatement of the agreement as a way to avoid potentially lengthy re-procurement in a highly specialised market. At this stage, Kier can work with the client and designers on the technical specification, programme, buildability, costs and construction risks ahead of major site delivery. No standalone H50 pre-construction contract value was disclosed.

The distinction matters because specialist laboratories pose complex delivery requirements long before concrete is poured. High-containment facilities need carefully designed ventilation, pressure controls, filtration, access systems, waste arrangements and building services that support safe research operations. Construction sequencing and commissioning procedures must take account of the consequences of equipment failure, maintenance work and contamination controls. These requirements can affect the building’s layout as well as the way contractors and specialist suppliers coordinate during construction.

The new campus is intended to bring together UKHSA’s scientific estate and administrative functions, providing facilities to support responses to serious public-health threats. Funding for the wider programme was allocated under the 2025 Spending Review. The project timetable outlined by Kier anticipates early works from 2028, main construction beginning in the fourth quarter of 2029 and the overall campus being complete and in service by 2038. Those dates underline the long lead times involved in establishing highly specialised public-sector infrastructure.

For construction and engineering suppliers, the development offers a demanding mix of building, process engineering and scientific equipment coordination. Contractors must accommodate laboratories whose technical specification can require more intensive integration than conventional commercial buildings. Testing and validation during commissioning are essential because the operational performance of building systems forms part of the facility’s ability to manage biological risks. Delivery schedules also need to account for technical design approvals and procurement of specialised components.

Kier’s Strategic Projects business has experience in healthcare and wider public infrastructure. Earlier in 2026, the group was appointed to work on a new Hinchingbrooke Hospital scheme with a cited value of approximately £500m. Its involvement in H50 broadens that portfolio into the high-containment scientific estate, although hospital and containment laboratory requirements differ materially. Previous project experience is relevant to capability, but it does not remove the need for careful planning, specialist design expertise and contract management.

Pre-construction collaboration can also reduce the danger that a laboratory’s architectural design develops separately from its operational systems. Scientists, engineers, safety specialists and construction managers must agree the location of containment boundaries, plant access, maintenance routes and future replacement needs before those choices become difficult to change. Even small alterations late in the programme can be expensive when they affect critical ventilation or security arrangements. A detailed early-stage design can provide better visibility of those risks, but it does not eliminate them. The client’s eventual procurement and project controls will remain central to whether the long-term programme meets its budget and operational timetable.

Kier Strategic Projects managing director Spencer Baber described the facility as a highly complex piece of scientific infrastructure. The next deliverables concern the technical design and sequencing required for a safe, buildable laboratory, while early works for the wider campus are expected from 2028 and main construction from late 2029. UKHSA’s published programme aims to bring the campus into service by 2038; the separate H50 construction contract and subsequent delivery milestones should not be inferred from the restarted planning agreement.

—